A mechanistic advance in understanding RSV pathogenesis, but still a long way from therapy

Am J Respir Cell Mol Biol. 2007 Oct;37(4):375-7. doi: 10.1165/rcmb.2007-0003ED.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Aged
  • Airway Obstruction / drug therapy
  • Animals
  • Antibodies, Viral / therapeutic use
  • Antiviral Agents / therapeutic use
  • Cattle
  • Humans
  • Infant
  • Isoxazoles / therapeutic use
  • Leflunomide
  • Mice
  • Respiratory Syncytial Virus Infections / drug therapy*
  • Respiratory Syncytial Viruses / pathogenicity*

Substances

  • Antibodies, Viral
  • Antiviral Agents
  • Isoxazoles
  • Leflunomide